If ceftriaxone must be used, do NOT administer ceftriaxone Dose should be given in conjunction with an oral dose of azithromycin due to
When ceftriaxone cannot be used for treatment of urogenital or rectal gonorrhea, two alternative options are available: cefixime 400 mg orally plus either azithromycin 1 g orally or doxycycline 100 mg twice daily orally for 7 days if ceftriaxone is not readily available, or azithromycin 2 g orally in a single dose if ceftriaxone cannot be given
Ceftriaxone is only given as an injection, either intramuscularly or intravenously. Ceftriaxone is less than 1% bioavailable if given orally. Volume of
Ceftriaxone 500 mg given intramuscularly in a single dose: If ceftriaxone is not available: Cefixime 800 mg orally in a single dose OR gentamicin 240 mg given intramuscularly in a single dose, PLUS azithromycin 2 g given orally in a single dose: For people allergic to ceftriaxone
ceftriaxone plus azithromycin versus ceftriaxone for the treatment of Neisseria gonorrhoeae on the resistome ORAL DOSE OF ZOLIFLODACIN COMPARED TO A
When ceftriaxone cannot be used for treatment of urogenital or rectal gonorrhea, two alternative options are available: cefixime 400 mg orally plus either azithromycin 1 g orally or doxycycline 100 mg twice daily orally for 7 days if ceftriaxone is not readily available, or azithromycin 2 g orally in a single dose if ceftriaxone cannot be given
Ceftriaxone has broader and stronger gram-negative coverage then first or Ceftriaxone is less than 1% bioavailable if given orally. Volume of
When ceftriaxone cannot be used for treatment of urogenital or rectal gonorrhea, two alternative options are available: cefixime 400 mg orally plus either azithromycin 1 g orally or doxycycline 100 mg twice daily orally for 7 days if ceftriaxone is not readily available, or azithromycin 2 g orally in a single dose if ceftriaxone cannot be given
Ceftriaxone (Rocephin) – IV, Cefotaxime - IV, Cefpodoxime - PO Ceftriaxone probably equivalent). Cefpodoxime useful as a step-down to oral after IV
Comments